Skip to Main

Search

Results 51 to 60 of 988 for ""

‘Timekeeper’ shapes body’s infection defenses, UTSW study finds

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-adrenaline-receptor.html

A newly discovered “timekeeper” for fighting infections dramatically shapes the body’s immune defenses.

UT Southwestern Q&A: What you need to know about the measles: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/march-qa-measles.html

The outbreak of measles that started in West Texas in January and spread to other regions and states has focused renewed attention on a childhood disease that had been eliminated in the United States in recent decades.

UT Southwestern biochemist Zhijian ‘James’ Chen to receive 2026 Brinster Prize

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-brinster-prize.html

Zhijian “James” Chen, Ph.D., Professor in the Department of Molecular Biology at UT Southwestern Medical Center and one of the world’s top researchers on innate immunity, has been awarded the 2026 Elaine Redding Brinster Prize in Science or Medicine.

In Memoriam: David J. Mangelsdorf, Ph.D., pioneer in orphan nuclear receptor research and Chair of Pharmacology

https://www.utsouthwestern.edu/newsroom/articles/year-2025/aug-mangelsdorf.html

In Memoriam: David J. Mangelsdorf, Ph.D., pioneer in orphan nuclear receptor research and Chair of Pharmacology Published on: August 09, 2025 • By: Newsroom Share Share on Facebook Share on Twitter Share on LinkedIn Email this page Print this page DALLAS – Aug. 9, 2025 – David J. Mangelsdorf, Ph.D., …

Higher dose of semaglutide increases weight loss, metabolic benefits: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-semaglutide.html

Tripling the standard dose of semaglutide, a popular drug prescribed to treat obesity, led to significantly greater weight loss and associated metabolic benefits without increased risk of serious side effects, a multicenter clinical trial led by a UT Southwestern Medical Center researcher shows.

UTSW named Specialized Program of Research Excellence for liver cancer

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-liver-cancer.html

The Liver Tumor Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center has been selected by the National Cancer Institute as a Specialized Program of Research Excellence (SPORE).

Food as medicine: UTSW advances clinical nutrition care

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-clinical-nutrition.html

A novel clinical pilot program at UT Southwestern Medical Center is transforming the role of nutrition education in patient care.

Biomarkers linked to side effects from cancer immunotherapy

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-immunotherapy-biomarkers.html

A team led by UT Southwestern Medical Center scientists has identified early signals from the immune system that could help predict which cancer patients are most likely to develop harmful side effects from immunotherapy.

Social Media: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/media-relations/social-media.html

Get social with us!

Obesity in childhood raises risk of experiencing weight stigma: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/may-obesity-in-childhood.html

Adults who developed severe obesity before the age of 18 were nearly three times more likely than those who developed the condition later to be subjected to severe experienced weight stigma (EWS), a study led by UT Southwestern Medical Center researchers shows.